1. Home
  2. ICD-10-PCS MS-DRG V41.0
  3. Procedure Codes in MS-DRG 016 - AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC

Procedure Codes in MS-DRG 016 - AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC

The Medicare Severity Diagnosis-Related Group or MS-DRG is a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). This is the group for Procedure Codes in MS-DRG 016 - AUTOLOGOUS BONE MARROW TRANSPLANT WITH Complication Comorbidity/Major Complication or Comorbidity diseases in version MS-DRG V41.0 applicable from 10/01/2023 through 09/30/2024.

MS-DRG MS-DRG Title MCD Relative Weight Geometric LOS Arithmetic LOS
016 AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC 6.1770 Relative Weight
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.		 6.18 Geometric Length of Stay
The geometric mean length of stay (GMLOS) is used by Medicare to calculate the reimbursement for patients whose medical treatment takes a much longer or shorter time than average.		 16.60 Arithmetic Length of Stay
The average length of stay (ALOS) reflects the average number of days a patient spends in a hospital for each admission.

ICD-10-PCS Codes in Diagnostic Related Group


  • 3023
    • 30233AZ Transfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach
    • 30233C0 Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Peripheral Vein, Percutaneous Approach
    • 30233G0 Transfusion of Autologous Bone Marrow into Peripheral Vein, Percutaneous Approach
    • 30233X0 Transfusion of Autologous Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach
    • 30233Y0 Transfusion of Autologous Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach
  • 3024
    • 30243AZ Transfusion of Embryonic Stem Cells into Central Vein, Percutaneous Approach
    • 30243C0 Transfusion of Autologous Hematopoietic Stem/Progenitor Cells, Genetically Modified into Central Vein, Percutaneous Approach
    • 30243G0 Transfusion of Autologous Bone Marrow into Central Vein, Percutaneous Approach
    • 30243X0 Transfusion of Autologous Cord Blood Stem Cells into Central Vein, Percutaneous Approach
    • 30243Y0 Transfusion of Autologous Hematopoietic Stem Cells into Central Vein, Percutaneous Approach
  • XW13
    • XW133B8 Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
    • XW133F8 Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
    • XW133G8 Transfusion of OTL-200 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
    • XW133H9 Transfusion of Lovotibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 9
    • XW133J8 Transfusion of Exagamglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
  • XW14
    • XW143B8 Transfusion of Betibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8
    • XW143F8 Transfusion of OTL-103 into Central Vein, Percutaneous Approach, New Technology Group 8
    • XW143G8 Transfusion of OTL-200 into Central Vein, Percutaneous Approach, New Technology Group 8
    • XW143H9 Transfusion of Lovotibeglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 9
    • XW143J8 Transfusion of Exagamglogene Autotemcel into Central Vein, Percutaneous Approach, New Technology Group 8